ClinicalTrials.Veeva

Menu

Study of the Effectiveness of The COVID-19 Vaccine

U

Universitas Sebelas Maret

Status

Completed

Conditions

COVID-19

Treatments

Diagnostic Test: COVID-19 Antibody

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This descriptive study examines neutralizing antibody levels against COVID-19 in health workers before and after the 2nd booster of the COVID-19 vaccine in Surakarta, Indonesia.

Full description

This research is a cross-sectional study with a descriptive-analytic design, community-based, of adults who live in Surakarta (age 18 years and over) using the Google form. The inclusion criteria were health workers receiving the third or second dose of the COVID-19 vaccine. Quantitative antibody titers are checked at Prodia's laboratory. Other variables examined were the number and date of vaccination, age, sex, comorbid diseases, body mass index, AEFI symptoms after the vaccine, and history of being infected with COVID-19. In the statistical analysis using the different and regression correlation tests, the significance level of P is less than 0.05.

Enrollment

100 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Health workers who receive the second booster of COVID-19 vaccination

Exclusion criteria

  • Pregnancy

Trial design

100 participants in 1 patient group

Health worker
Description:
A health worker who received a second dose of booster COVID19 vaccine
Treatment:
Diagnostic Test: COVID-19 Antibody

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems